CONSTANT LEVERAGE LONG - FAGRON Stock

FU5FB

NLBNPNL1S5T7

Real-time Euronext Paris 03:32:38 2024-05-15 EDT
2.185 ^EUR	+1.39%

Current month	+18.41%
1 month	+39.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart FAGRON N.V.

Latest news about FAGRON N.V.

Fagron N : NV, - shareholders approve all voting items at AGM and EGM	05-14	PU
Fagron shareholders approve all voting items at AGM and EGM	05-13	GL
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting	04-15	AQ
Fagron N : NV, - publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2024	04-12	PU

More news

Quotes 5-day view

Date	Price	Change
24-05-15	2.185	+1.39%
24-05-14	2.155	+4.61%
24-05-13	2.06	-3.51%
24-05-10	2.135	+3.39%
24-05-09	2.065	+1.47%

Real-time Euronext Paris

Last update May 15, 2024 at 03:32 am

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	FAGRON N.V.
Issuer	BNP Paribas
	FU5FB
ISIN	NLBNPNL1S5T7
Date issued	2022-04-11
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.44 €
Lowest since issue	0.447 €
Spread	0.03 €
Spread %	1.36%

Company Profile

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.

Sector

More about the company

Ratings for Fagron N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Fagron N.V.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19 EUR

Average target price

21.7 EUR

Spread / Average Target

+14.21%

Consensus